EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,658 | -82.3% | 41,500 | -59.1% | 0.00% | -100.0% |
| Q2 2023 | $71,456 | -61.0% | 101,500 | -50.3% | 0.00% | -50.0% |
| Q1 2023 | $183,282 | +33.6% | 204,350 | +75.7% | 0.01% | +20.0% |
| Q4 2022 | $137,234 | -71.5% | 116,300 | +81.9% | 0.01% | -72.2% |
| Q3 2022 | $482,000 | +20.2% | 63,950 | +0.4% | 0.02% | +28.6% |
| Q2 2022 | $401,000 | -22.4% | 63,700 | +2.2% | 0.01% | -6.7% |
| Q1 2022 | $517,000 | +59.1% | 62,300 | -0.5% | 0.02% | +66.7% |
| Q4 2021 | $325,000 | -20.3% | 62,600 | +2.4% | 0.01% | -25.0% |
| Q3 2021 | $408,000 | +200.0% | 61,150 | +283.4% | 0.01% | +200.0% |
| Q2 2021 | $136,000 | +0.7% | 15,950 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $135,000 | -27.8% | 15,200 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $187,000 | – | 15,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |